Immobilized RNase A gel material as well as preparation method and application thereof

By immobilizing RNase A to form gel materials using sodium alginate hydrogel, the problems of low RNA removal efficiency and free nucleic acid contamination are solved, and efficient RNA removal and high-quality biologics production are achieved.

CN119060997APending Publication Date: 2024-12-03SHANDONG UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411342960.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-25
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The prior art has low removal efficiency during the RNA removal process and is prone to contamination of free nucleases, making it difficult to meet the requirements of high-quality biological agents.

Method used

Using sodium alginate hydrogel as a carrier, RNase A is immobilized by mixing and standing hardening to form an immobilized RNase A gel material for specific removal of RNA.

Benefits of technology

The efficient removal efficiency of RNA is achieved, with a removal rate of more than 99.5%, avoiding secondary contamination of free nucleases and improving the reusability of RNase A.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060997A_ABST
    Figure CN119060997A_ABST
Patent Text Reader

Abstract

The invention discloses an immobilized RNase A gel material as well as a preparation method and application thereof, and belongs to the technical field of nucleic acid removal. The preparation method provided by the invention comprises the following steps: uniformly mixing an RNase A solution and a sodium alginate aqueous solution in a volume ratio of 1: (3-5) to obtain a mixed solution; and preparing the mixed solution into coagulation beads, and then placing the coagulation beads in a calcium ion solution for standing and hardening. The preparation method of the immobilized RNase A gel material is simple, the raw materials are wide in source and low in price, the prepared immobilized RNase A gel material has a very good specific RNA removal effect, the removal efficiency of RNA within 10 min can reach 99.5% or above, the secondary pollution problem of free nuclease is effectively avoided, and the immobilized RNase A gel material is suitable for industrial production. Meanwhile, the reusability of RNase A is improved, and the method has a good application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of nucleic acid removal, and in particular to an immobilized RNase A gel material and a preparation method and application thereof. Background Art

[0002] The information disclosed in the background of the invention is only intended to enhance the understanding of the overall background of the invention and should not be necessarily regarded as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.

[0003] Biological preparations such as vaccines refer to biological products that can prevent, treat, and diagnose corresponding infectious diseases or other related diseases. They are formed by processing microorganisms such as bacteria, rickettsia, viruses, and their metabolites. As the main raw material for the production of biological preparations, the quality of the cell matrix is ​​crucial to the production of biological products such as vaccines. For example, it has an important impact on the quality, yield, and safety of its products. RNA exists in the cell matrix as a potential risk factor. In order to ensure that biological products have extremely high quality and safety, strict quality control must be carried out on it.

[0004] In addition to screening and testing raw materials, ensuring they meet quality standards, and strictly implementing a series of operating and monitoring steps during the production process, effective methods and technologies are also needed to remove or kill potential viral infections and cell remnants, and effectively remove residual RNA.

[0005] Anion exchange chromatography is a commonly used method for RNA removal, but its RNA removal efficiency and removal rate are low (generally less than 90%), which makes it difficult to meet high quality requirements. Restriction nuclease-based biological agent removal methods have been widely used in various industries in pharmaceutical and bioengineering production; but the current use of nucleases for nucleic acid removal takes a long time and has low removal efficiency; at the same time, the addition of free nucleases also creates new contamination for biological agents. RNaseA is an endoribonuclease that can specifically degrade single-stranded RNA at C and U residues. Immobilizing RNase A is an important means to avoid free enzyme contamination, but after the enzyme is immobilized, it is likely to cause a further decrease in RNA removal efficiency, and the carrier used for enzyme immobilization may have an adverse effect on RNA removal due to factors such as charge effects.

[0006] Therefore, how to provide a material that can immobilize RNase A and achieve efficient RNA removal is an urgent problem to be solved. Summary of the invention

[0007] In view of this, the present invention provides an immobilized RNase A gel material and a preparation method and application thereof, which solve the problems of secondary contamination of free enzyme and low RNA removal efficiency.

[0008] In a first aspect, the present invention provides a method for preparing an immobilized RNase A gel material, comprising the following steps:

[0009] The RNase A solution and the sodium alginate aqueous solution are mixed uniformly at a volume ratio of 1:(3-5) to obtain a mixed solution;

[0010] The mixed solution is made into beads, which are then placed in a calcium ion solution and allowed to stand and harden to obtain the product.

[0011] Preferably, the concentration of the RNase A solution is 0.5-2 mg / mL.

[0012] Preferably, the concentration of the sodium alginate aqueous solution is 1-2 wt %.

[0013] Preferably, in the step of uniformly mixing to obtain a mixed solution, the mixing is performed by vortex mixing.

[0014] Preferably, the diameter of the beads is 0.3 to 3 mm.

[0015] Preferably, the concentration of the calcium ion solution is 0.1-0.3M.

[0016] Preferably, the calcium ion solution is a solution formed by dissolving a calcium salt in water, and the calcium salt is selected from calcium chloride, calcium bromide, calcium iodide or calcium nitrate.

[0017] Preferably, the static hardening time is 2 to 5 hours, and the static hardening temperature is 2 to 6°C.

[0018] In a second aspect, the present invention provides an immobilized RNase A gel material prepared by the above preparation method.

[0019] In a third aspect, the present invention provides the use of the above-mentioned immobilized RNase A gel material in RNA-specific removal.

[0020] Preferably, during the RNA specific removal process, the pH is 6-8 and the temperature is 50-60°C.

[0021] Compared with the prior art, the present invention has achieved the following beneficial effects:

[0022] The preparation method of the immobilized RNase A gel material provided by the present invention is simple, the raw material source is wide and the price is low, the prepared immobilized RNase A gel material has a very good specific RNA removal effect, the RNA removal efficiency within 10 minutes can be as high as more than 99.5%, and the secondary contamination problem of free nucleases is effectively avoided, while the reusability of RNase A is improved, and the immobilized RNase A has good application prospects. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] The drawings constituting part of the present invention are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their description are used to explain the present invention and do not constitute an improper limitation of the present invention. Obviously, for those skilled in the art, other drawings can be obtained based on these drawings without creative work.

[0024] Figure 1 is a comparison chart of 16SrRNA concentration data before and after treatment of 16SrRNA using immobilized RNase A gel material at different treatment times in Example 2 of the present invention;

[0025] Figure 2 is a comparison chart of sul1 concentration data before and after treatment of sul1 using immobilized RNase A gel material at different treatment times in Example 2 of the present invention;

[0026] Figure 3 16SrRNA removal rate data at different pH values ​​in Example 3 of the present invention (a) and nucleic acid concentration change diagram before and after treatment (b);

[0027] Figure 4 16SrRNA removal rate at different temperatures in Example 3 of the present invention (a) and nucleic acid concentration change before and after treatment (b). DETAILED DESCRIPTION

[0028] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.

[0029] The present invention provides a method for preparing an immobilized RNase A gel material, comprising the following steps:

[0030] The RNase A solution and the sodium alginate aqueous solution are mixed uniformly at a volume ratio of 1:(3-5) to obtain a mixed solution;

[0031] The mixed solution is made into beads, which are then placed in a calcium ion solution and allowed to stand and harden to obtain the product.

[0032] The present invention uses sodium alginate hydrogel as an immobilization carrier of RNase A, and fixes RNase A on the surface of gel beads by embedding. The present invention finds that when RNase A is fixed by using this technical solution, the removal efficiency of RNA is not significantly reduced, and the secondary contamination of free enzyme can be avoided, thereby increasing the reuse rate of RNase A.

[0033] In the present invention, the concentration of the RNase A solution is 0.5-2 mg / mL, preferably 1 mg / mL. The RNase A solution of the present invention is preferably directly obtained from the market, and the present invention does not impose any special restrictions on its specific source.

[0034] In the present invention, the concentration of the sodium alginate aqueous solution is 1-2wt%, more preferably 2wt%. The sodium alginate aqueous solution is a viscous solution, which is easy to form subsequent beads. The present invention does not impose any special restrictions on its preparation method, and the preparation method of the sodium alginate aqueous solution commonly used in the art can be used.

[0035] In the step of uniformly mixing to obtain a mixed solution of the present invention, the mixing is performed by vortex mixing. The present invention does not impose any particular limitation on the specific vortex mixing method, and the vortex mixing method commonly used in the art can be used.

[0036] In the present invention, the specific method of making the mixed solution into beads is preferably: injecting the mixed solution into beads using a syringe. Those skilled in the art may also use other methods to make beads, and the present invention does not impose any special restrictions on this. The diameter of the beads in the present invention is preferably 0.3 to 3 mm.

[0037] In the present invention, the concentration of the calcium ion solution is 0.1 to 0.3 M. The calcium ion solution is a solution formed by dissolving a calcium salt in water, and the calcium salt is selected from calcium chloride, calcium bromide, calcium iodide or calcium nitrate, and calcium chloride is most preferred. In the aqueous solution, calcium ions are attracted by the negative charge of sodium alginate, thereby forming a series of calcium ion-sodium alginate complexes, which are cross-linked together to form a cross-chain structure, thereby solidifying into a gel-like substance.

[0038] In the present invention, the standing hardening time is 2 to 5 hours, and the standing hardening temperature is 2 to 6° C. Standing at low temperature can ensure that RNase A is more stably fixed on the gel surface.

[0039] The present invention also provides an immobilized RNase A gel material prepared by the above preparation method.

[0040] The present invention also provides application of the immobilized RNase A gel material in RNA specific removal.

[0041] In the present invention, during the RNA specific removal process, the pH is preferably 6-8 and the temperature is preferably 50-60° C. Under the above conditions, the immobilized RNase A gel material can have a better RNA removal efficiency, and the removal rate within 10 minutes can be as high as 99.5% or more.

[0042] The technical solution of the present invention is further described below in conjunction with specific examples. In the following examples, the concentration of RNase A solution is 1 mg / mL.

[0043] Example 1

[0044] This embodiment provides a method for preparing an immobilized RNase A gel material.

[0045] RNase A solution and 2 wt% sodium alginate aqueous solution are mixed together in a volume ratio of 1:4, and the mixed solution is evenly dissolved using a vortex oscillator. The mixed solution is injected into beads with a diameter of about 1 mm, placed in a 0.2 M CaCl2 aqueous solution, and allowed to stand at 4°C for 2.5 h to harden.

[0046] Example 2

[0047] In this example, the immobilized RNase A gel material prepared in Example 1 was used to treat the sulfonamide resistance gene (sul1, DNA) and 16SrRNA in the sample to verify its efficiency and specificity.

[0048] The specific experimental process is as follows: 1 mg of the immobilized RNase A gel material prepared in Example 1 was taken, and sul1 and 16SrRNA were treated with the immobilized RNase A gel material for 1 hour, and samples were taken every 10 minutes for determination.

[0049] A real-time fluorescence quantitative nucleic acid amplification detection system (qPCR) was used to detect changes in nucleic acids before and after treatment with the immobilized RNase A gel material. The qPCR system and primers used are shown in Table 1, and the qPCR reaction system is shown in Table 2.

[0050] Table 1 Primer related information

[0051]

[0052] Note: In the table, F represents the upstream primer and R represents the downstream primer.

[0053] Table 2 qPCR reaction system

[0054]

[0055]

[0056] 1. Experimental results on the removal of 16SrRNA:

[0057] Figure 1 The 16SrRNA concentration data comparison chart of 16SrRNA before and after treatment with immobilized RNase A gel material at different treatment times. It can be seen that after treatment with immobilized RNase A gel material, the 16SrRNA concentration in the sample gradually decreased. Within 10 minutes, the 16SrRNA concentration increased from 4.14±0.07×10 9 The number of copies / mL was reduced to 10 7 copies / mL, and the removal rate reached 99.75%. At 60 minutes, the 16SrRNA concentration in the sample dropped to 10 6 copies / mL, and the removal rate reached 99.98%, which showed that the immobilized RNase A had a good removal effect on 16SrRNA in the sample.

[0058] 2. Results of the sul1 removal experiment:

[0059] Figure 2 The following is a comparison chart of sul1 concentration data before and after treatment with immobilized RNase A gel material at different treatment times. The results show that the copy number of sul1 in the sample treated with immobilized RNase A gel material basically did not change, and maintained a copy number close to the initial nucleic acid level within 60 minutes. This shows that the immobilized RNase A gel material has high specificity and can selectively remove target molecules (RNA).

[0060] Example 3

[0061] In this example, the immobilized RNase A gel material prepared in Example 1 was used to treat 16S rRNA in the sample to explore the effects of pH and temperature on the removal efficiency of 16S rRNA.

[0062] 1. Effect of pH value:

[0063] The treatment temperature was controlled at 25°C and the treatment time was 60 min. The removal efficiency of 16S rRNA was investigated at a pH of 2 to 12, and the pH was adjusted using hydrochloric acid and sodium hydroxide.

[0064] Figure 3 Figure 1 shows the removal rate of 16SrRNA at different pH values ​​(a) and the change of nucleic acid concentration before and after treatment (b). It can be seen that at pH 7, the nucleic acid removal efficiency is maintained at the highest level, and the 16SrRNA concentration can be reduced from 3.56±1.84×10 9The copies / mL was reduced to 6.51±4.68×10 6 copies / mL, the removal rate reached more than 99.82±0.13%; when the pH was 6 and 8, the removal rate decreased, and the 16SrRNA concentration was reduced from 1.23±0.40×10 10 copies / mL, 3.72±0.48×10 9 The copies / mL was reduced to 6.25±1.94×10 7 copies / mL, 2.91±2.41×10 7 copies / mL, the removal rates reached 99.49±0.40% and 99.22±0.65%; when the pH was 2, 4, 10, and 12, the removal rates further decreased, but still maintained a high level. Under this condition, the 16SrRNA concentration could be increased from 2.63±0.80×10 9 copies / mL, 4.69±0.39×10 9 copies / mL, 7.78±1.18×10 9 copies / mL, 4.53±2.00×10 9 The copies / mL was reduced to 7.09±1.37×10 8 copies / mL, 8.19±2.99×10 8 copies / mL, 7.51±6.51×10 8 copies / mL, 2.00±0.40×10 8 copies / mL. The removal rates were 73.04±5.21%, 82.53±6.37%, 90.35±8.37%, and 55.98±8.84%, respectively.

[0065] 2. Influence of temperature:

[0066] The treatment pH was controlled at 7, the treatment time was 60 min, and the removal efficiency of 16S rRNA was investigated at a temperature of 4-80°C.

[0067] Figure 4 Figure 1 shows the removal rate of 16SrRNA at different temperatures (a) and the change of nucleic acid concentration before and after treatment (b). From the results, it can be seen that the immobilized RNase A reached the optimal temperature at 50℃ and 60℃, and the concentration of 16SrRNA can be reduced from 4.14±0.0×10 9 copies / mL, 3.42±1.73×10 9 The copies / mL was reduced to 1.66±1.62×106 copies / mL, 4.48±3.54×10 6 copies / mL, and the removal rate reached 99.96±0.03% and 99.86±0.10%, and the 16SrRNA can be removed by about 3 orders of magnitude. When the temperature is 4℃, 25℃, and 80℃, the efficiency of nucleic acid is slightly reduced, and the concentration of 16SrRNA can be increased from 3.42±1.73×10 9 copies / mL decreased to 3.12±0.91×10 8 copies / mL, 1.19±0.99×10 8 copies / mL, 1.10±0.22×10 8 copies / mL, and the removal rates were 90.87±2.67%, 96.52±2.91%, and 96.79±0.63%, respectively. Only about one order of magnitude of nucleic acid can be removed.

[0068] Comparative Example

[0069] In this comparative example, free RNase A was used to treat the 16SrRNA in the sample. When the treatment temperature was 50°C, the pH was 7, and the treatment time was 60 min, the concentration of 16SrRNA could be increased from 4.14±0.0×10 9 The copies / mL decreased to 1.66±1.62×10 6 copies / mL, and the nucleic acid removal rate was 99.96±0.03%.

[0070] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for preparing an immobilized RNase A gel material, characterized in that: The steps include: The RNase A solution and the sodium alginate aqueous solution are mixed uniformly at a volume ratio of 1:(3-5) to obtain a mixed solution; The mixed solution is made into beads, which are then placed in a calcium ion solution and allowed to stand and harden to obtain the product.

2. The preparation method according to claim 1, characterized in that The concentration of the RNase A solution is 0.5-2 mg / mL; the concentration of the sodium alginate aqueous solution is 1-2 wt %.

3. The preparation method according to claim 1, characterized in that: In the step of uniformly mixing to obtain a mixed solution, the mixing is performed by vortex mixing.

4. The preparation method according to claim 1, characterized in that: The diameter of the condensed beads is 0.3-3 mm.

5. The preparation method according to claim 1, characterized in that: The concentration of the calcium ion solution is 0.1-0.3M.

6. The preparation method according to claim 1, characterized in that: The calcium ion solution is a solution formed by dissolving a calcium salt in water, and the calcium salt is selected from calcium chloride, calcium bromide, calcium iodide or calcium nitrate.

7. The preparation method according to claim 1, characterized in that: The static hardening time is 2 to 5 hours, and the static hardening temperature is 2 to 6°C.

8. The immobilized RNase A gel material prepared by the preparation method according to any one of claims 1 to 7.

9. Use of the immobilized RNase A gel material as claimed in claim 8 in RNA specific removal.

10. The use according to claim 9, characterized in that During the RNA specific removal process, the pH is 6-8 and the temperature is 50-60°C.